Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update

Go back to Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update

Forte Biosciences (FBRX) Reports Q2 Loss of $9.52

August 10, 2020 4:59 PM EDT

Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($9.52), versus ($0.30) reported last year.

We are very happy to have concluded the reverse merger on June 15th and in that process, brought on a very well-respected group of investors, including Alger, BVF Partners, Franklin... More